CD8A and hepatocellular carcinoma: Mice treated with the synthetic oncolytic adenovirus were protected from HCC tumor rechallenge and had significantly increased intra-tumoral lymphocytes, as well as a significantly higher proportion of interferon (IFN)-γ producing and Ki67+ CD8+ T cells (74).